Azaindole derivatives, process for their preparation, and their use as antitumor agents

Details for Australian Patent Application No. 2001266079 (hide)

Owner Pharmacia Italia S.p.A.

Inventors Pittala', Valeria; Varasi, Mario; Longo, Antonio; Pevarello, Paolo; Traquandi, Gabriella; Orsini, Paolo; Brasca, Maria Gabriella; Vulpetti, Anna

Agent Griffith Hack

Pub. Number AU-B-2001266079

PCT Pub. Number WO01/98299

Priority 09597274 19.06.00 US

Filing date 13 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 24 August 2006

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

24 August 2006 Application Accepted

  Published as AU-B-2001266079

21 December 2006 Standard Patent Sealed

15 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001266081

2001266078-A novel human homologue of the DBF4/ASK1 protein, nucleic acids, and methods related to the same